We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

World’s First Rapid Saliva-Based Pregnancy Test Set for Multi-Country Launch

By LabMedica International staff writers
Posted on 09 Nov 2022
Print article
Image: SaliStick is the first pregnancy test that does not require urine (Photo courtesy of Salignostics)
Image: SaliStick is the first pregnancy test that does not require urine (Photo courtesy of Salignostics)

Saliva contains over 5,000 identified proteins. With significant overlap to blood, saliva is considered the second most important body-fluid for diagnostics. Now, the world’s first saliva-based pregnancy test is all set to arrive in stores across Europe, South Africa, United Arab Emirates, and Israel in the first quarter of 2023. By analyzing saliva, the test completely removes the need for blood and urine samples when testing for pregnancy.

Salistick from Salignostics (Jerusalem, Israel) is the first rapid saliva-based pregnancy test with a new and improved user-experience, and high accuracy for early pregnancy detection. The kit is based on the company’s revolutionary technology which opens the door for a sensitive detection of the pregnancy hormone β-hCG in saliva. The simple, easy to use test can be done anywhere, at any time, without the need for a restroom and delivers accurate results in no more than 10 minutes.

Salistick has already been approved by the European CE certification and has received Medical Devices and Accessories approval from Israel’s Ministry of Health. Salignostics has also completed a 510(K) initial Q-submission of SaliStick to the US FDA. In order to support the commercialization of SaliStick, Salignostics has established a new manufacturing facility in Israel with a monthly production capacity of one million units.

Related Links:

Gold Supplier
Chemiluminescence Immunoassay Analyzer
Direct LDL Assay
Direct LDL-C
Trypanosoma Brucei Gambiense Antibody Test
HAT Sero K-SeT
Fecal Occult Blood Test
iFOB Assay

Print article


Clinical Chem.

view channel
Image: ELISA kit for liver-type fatty acid–binding protein (L-FABP). The level of L-FABP present in urine reflects the level of renal tubular dysfunction (Photo courtesy of Sekisui Medical Co)

Urinary Biomarkers Predict Weaning From Acute Dialysis Therapy

Acute kidney injury is associated with a higher risk of chronic kidney disease (CKD), end-stage renal disease, and long-term adverse cardiovascular effects. Critically ill patients with acute kidney injury... Read more


view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more


view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more


view channel
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.